ACESION PHARMA ApS: Financial statements 2019
CVR: 34083738
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
ACESION PHARMA ApS (CVR 34083738) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -35,793,780 and a net result of DKK -41,223,161 compared with DKK -25,088,392 the year before. Equity in the 2019 report amounted to DKK 523,693. The solvency ratio was 1.7%. The company had 7 employees in the financial year.
- Gross Profit
- DKK -35,793,780
- Profit/Loss
- DKK -41,223,161
- Equity
- DKK 523,693
- Total Assets
- DKK 31,475,328
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -35.8 mio. | -41.2 mio. | 524 t. | 7 |
| 2018 | - | -18.6 mio. | -25.1 mio. | -6.5 mio. | 10 |
| 2017 | - | -17.5 mio. | -24 mio. | -9.9 mio. | 12 |
| 2016 | - | -14.4 mio. | -18.3 mio. | 14.1 mio. | - |
| 2015 | - | -8.5 mio. | -9.8 mio. | 1.5 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of September 9, 2019, Morten Døssing has joined the board of directors of ACESION PHARMA ApS.
As of September 9, 2019, Karen Juo-Lai Chu has joined the board of directors of ACESION PHARMA ApS.
As of September 9, 2019, Stephan Christgau has left the board of directors of ACESION PHARMA ApS.
As of September 9, 2019, Duan Xiang has left the board of directors of ACESION PHARMA ApS.
ACESION PHARMA ApS has published its annual report for 2018. Gross profit came to DKK -18,647,333, and the net result was DKK -25,088,392.
As of January 23, 2019, Duan Xiang has joined the board of directors of ACESION PHARMA ApS.
About ACESION PHARMA ApS
ACESION PHARMA ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Gaarsdal Holst. The board consists of Jørgen Søberg Petersen (chair), Benjamin Bruno Thorner, Nik Economopoulos and Timothy Michael Shannon. The company's owners include Novo Holdings A/S, Canaan XII L.P. and Alpha Wave Ventures II, LP. The company has 14 employees (2018). In 2025, the company reported a net result of DKK -59,597,000 compared with DKK -43,033,000 the year before. Equity in the 2025 report amounted to DKK 276,067,000.